MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Life expectancy with and without Parkinson’s disease in the general population

    L. Dommershuijsen, A.. Ikram, K. Ikram (Rotterdam, Netherlands)

    Objective: To determine (1) the burden of Parkinson’s disease (PD) in the general population and (2) the life expectancy after the diagnosis of PD. Background:…
  • 2019 International Congress

    Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland

    V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard (Lausanne, Switzerland)

    Objective: The objective of the study was to determine whether PD prevalence exhibit any spatial dependence in order to get hypothesis on PD risk or…
  • 2019 International Congress

    Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease

    F. Hopfner, M. Wod, G. Höglinger, M. Blaabjerg, T. Roesler, G. Kuhlenbäumer, K. Christensen, G. Deuschl, A. Pottegård (Kiel, Germany)

    Objective: Verification of the previously reported association between chronic use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson’s disease (PD),…
  • 2019 International Congress

    Frequency and pattern of movement disorders in a Neurologic clinic in North Central Nigeria: a 3- year review

    E. Iwuozo, R. Obiako (Makurdi, Nigeria)

    Objective: This study evaluated the frequency and pattern of movement disorders in a neurology clinic in a tertiary hospital in North Central Nigeria over a…
  • 2019 International Congress

    Frequency of Cardiovascular Abnormalities in Mexican Patients with Early Parkinson´s Disease

    JA. Juárez, M. Violante, A. Arriaga, A. González, A. Salas, L. Vidal, R. Vicioso, C. Roa, I. López, M. Soto (Mexico, Mexico)

    Objective: To determine frequency of cardiovascular abnormalities and autonomic dysfunction in the early course of Parkinson's disease Background: Parkinson´s disease (PD) is a neurodegenerative disease…
  • 2019 International Congress

    Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study

    X. Kang, A. Ploner, J. Ludvigsson, D. Williams, N. Pedersen, K. Wirdefeldt (Solna, Sweden)

    Objective: To examine whether individuals with a history of Clostridium difficile (C. diff) infection have an elevated risk of developing Parkinson’s disease (PD). Background: The…
  • 2019 International Congress

    Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions

    A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)

    Objective: To explore the views of PD healthcare professionals on the use of e-PROMs. Background: Assessment of motor AND non-motor symptoms are critical to the…
  • 2019 International Congress

    Long-term Yearly Trends of Feeding Tube Placement in Neurodegenerative Disorders

    D. Kim, R. Jones, A. D'Abreu, J. Friedman, U. Akbar (Providence, RI, USA)

    Objective: We sought to determine the incidence of feeding tube (FT) placement in Alzheimer's disease (AD), Parkinson's disease (PD), or amyotrophic lateral sclerosis(ALS) population, describe…
  • 2019 International Congress

    Inflammatory Conditions in Parkinson’s Disease

    B. Krishnamachari, S. Shermon, M. Goldfinger, A. Leder, B. Harper, J. Donoghue (Old Westbury, NY, USA)

    Objective: The goal was to conduct a case-control study to assess associations between Parkinson disease (PD) and inflammatory conditions including allergies, asthma, eczema, atopic conditions,…
  • 2019 International Congress

    Movement Disorders Spectrum in a Private Practice setup in India : A 7 Year Study

    P. Kukkle (Bangalore, India)

    Objective: To study the pattern and spectrum of Movement Disorders patients seen at a Private Movement Disorders Clinic in India Background: There is lack of…
  • « Previous Page
  • 1
  • …
  • 1152
  • 1153
  • 1154
  • 1155
  • 1156
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley